Ardsley drugmaker to pay $525 million for Civitas Therapeutics
NEW YORK – Acorda Therapeutics Inc. of Ardsley plans to buy privately held Civitas Therapeutics for $525 million in cash as the drugmaker seeks to expand into treatments for Parkinson's disease.
10:05 JPMorgan, HSBC, Credit Agricole Fined $521 Million Over Euribor8
06:10 Sources: Carlos Gomez, Rangers agree on 1-year, $11.5 million deal10
02:14 Must-pass spending bill includes money for Flint and path for Mattis confirmation11
13:34 Grammy Nominations 2017: How to Watch the Livestream, Get the Full List!12